Cargando…

Comparison of uninterrupted direct oral anticoagulation with vitamin‐K antagonists during AF‐ablation in the clinical routine. A single center register

BACKGROUND: Uninterrupted direct oral anticoagulation (DOAC) in AF‐ablation is recommended, proven by randomized trials. The outcome and the periinterventional differences between DOACs and VKA in the real world clinical practice are discussed controversial. HYPOTHESIS: To investigate efficiency and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christoph, Marian, Youssef, Akram, Svitil, Jan, Forkmann, Mathias, Huo, Yan, Gaspar, Thomas, Francke, Alexander, Schoen, Steffen, Quick, Silvio, Wunderlich, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428011/ https://www.ncbi.nlm.nih.gov/pubmed/34312888 http://dx.doi.org/10.1002/clc.23676

Ejemplares similares

Simple periprocedural precautions to reduce Doppler microembolic signals during AF ablation
por: Christoph, Marian, et al.
Publicado: (2021)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
Publicado: (2019)

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
por: Cappato, Riccardo, et al.
Publicado: (2015)

Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
por: De Heide, John, et al.
Publicado: (2018)

Transvenous lead extraction on uninterrupted anticoagulation: A safe approach?
por: Vinit, Sawhney, et al.
Publicado: (2021)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021)

Uninterruptible power supplies
por: Platts, John, et al.
Publicado: (1991)

Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study
por: Tang, Lihong, et al.
Publicado: (2020)

Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment
por: Zhang, Rong-feng, et al.
Publicado: (2021)

Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients
por: Leiria, Tiago Luiz Luz, et al.
Publicado: (2018)

Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
por: Calkins, Hugh, et al.
Publicado: (2019)

Safety of endoscopic ultrasound-guided tissue acquisition with uninterrupted direct oral anticoagulation in a swine model
por: Garcia Garcia de Paredes, Ana, et al.
Publicado: (2023)

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques
por: Schiavone, Marco, et al.
Publicado: (2023)

Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis
por: Ottóffy, Máté, et al.
Publicado: (2020)

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis
por: Alasnag, Mirvat
Publicado: (2019)

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis
por: Chongprasertpon, Napohn, et al.
Publicado: (2019)

Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation
por: Harada, Masahide, et al.
Publicado: (2020)

Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
por: Basu‐Ray, Indranill, et al.
Publicado: (2021)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary
por: Patel, Sankalp P., et al.
Publicado: (2022)

SAFETY AND EFFICACY OF SAME-DAY ELECTIVE CORONARY ANGIOGRAPHY AND SYNCHRONIZED CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION WITH UNINTERRUPTED ANTICOAGULATION
por: Gallen, Rory, et al.
Publicado: (2021)

Comparison of Interrupted and Uninterrupted Anticoagulation Therapy for Patients With Atrial Fibrillation Undergoing Catheter Ablation: A Meta-Analysis
por: Jamil, Sidra, et al.
Publicado: (2022)

Uninterruptible Power Supplies and Active Filters
por: Emadi, Ali
Publicado: (2004)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019)

Uninterrupted and reusable source for the controlled growth of nanowires
por: Sugavaneshwar, R. P., et al.
Publicado: (2013)

Three Quarters of a Century of Uninterrupted Publication
Publicado: (1940)

Case of Sunstroke: Insidious Onset and Uninterrupted Recovery
por: Crawford, G. S.
Publicado: (1896)

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
por: De Luca, Leonardo, et al.
Publicado: (2021)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF
por: McManus, David D., et al.
Publicado: (2019)

Safety of catheter ablation of atrial fibrillation without pre‐ or peri‐procedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation
por: Efremidis, Michael, et al.
Publicado: (2020)

EPHEDRA, THE OLDEST MEDICINAL PLANT WITH THE HISTORY OF AN UNINTERRUPTED USE
por: Mahdihassan, S.
Publicado: (1987)

A Novel Option of Uninterrupted Closure of Surgical Wounds
por: Sulamanidze, Marlen A, et al.
Publicado: (2009)

Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
por: Kornfeld, Hannah, et al.
Publicado: (2021)

Living, uninterrupted: the positive potential of low impact construction
por: Boake, Terri Meyer
Publicado: (2022)

The evolution of the Journal covers: 55 years of uninterrupted progress
por: Stammers, Alfred H.
Publicado: (2023)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_690v63c9248plasrpmhcs6tdv7